Navigation Links
Deloitte Announces 2010 Technology Fast 500™ Rankings

NEW YORK, Oct. 20 /PRNewswire/ -- Deloitte today released the 2010 Technology Fast 500™, an annual ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Award winners were selected based on percentage fiscal year revenue growth from 2005 to 2009.  For the 13th consecutive year, there are more software companies on the Technology Fast 500™ than any other single sector.  Biotechnology companies surged ahead this year, comprising 18 percent of the list, the second most prevalent sector in the 2010 ranking.

"We congratulate the 2010 Deloitte Technology Fast 500 on this impressive achievement," said Phil Asmundson, vice chairman and Deloitte's U.S. technology, media & telecommunications leader. "Established sectors like software once again have a major presence in the ranking. However, nascent sectors like clean tech and media/entertainment should not be ignored, and we expect to see their numbers continue to grow on future Fast 500 rankings."

Sector Trends – Software and Biotech Dominate Software winners represent 38 percent of the overall list, making it the most prevalent sector.  Varicent Software Incorporated, a Toronto-based provider of incentive compensation and sales performance management software, is the top-ranked software company, placing sixth on the overall list with 40,269 percent growth from 2005 to 2009.

"One of the reasons software companies often grow so quickly is that their infrastructure costs are usually not as significant as other sectors," said Asmundson.  "As companies in other industries learn ways to leverage the disruptive power of cloud computing, they too can benefit from this competitive advantage.  Over time we expect to see this trend reflected in our rankings."

Biotech/pharma is the second most prevalent sector in this year's rankings, comprising 18 percent of the Technology Fast 500™.  These 87 companies had an average growth rate of 4,569 percent from 2005 to 2009.  The impressive average growth rate of biotech/pharma is demonstrated by having five biotech/pharma companies in the top 10.  These companies are Affymax, Inc. (ranked second), BioCryst Pharmaceuticals, Inc. (ranked fifth), Alexion Pharmaceuticals, Inc. (ranked seventh), Onyx Pharmaceuticals, Inc. (ranked ninth) and Celldex Therapeutics, Inc. (ranked 10th).  

The percentage of companies from industry sectors are represented on the Technology Fast 500™ as follows:

  • Software (38 percent)

  • Sector leader: Varicent Software Incorporated

  • Biotech/Pharma (18 percent)

  • Sector leader: Affymax, Inc.

  • Communications/Networking (11 percent)

  • Sector leader: Hughes Communications, Inc.

  • Internet (9 percent)

  • Sector leader: LeadQual, LLC

  • Medical Equipment (7 percent)

  • Sector leader: Genoptix, Inc.

  • Computers/Peripherals (5 percent)

  • Sector leader: PlumChoice

  • Clean Tech (4 percent)

  • Sector leader: Ener1, Inc

  • Scientific/Technical Instrumentation (3 percent)

  • Sector leader: Insulet Corporation

  • Semiconductor (3 percent)

  • Sector leader: Entropic Communications, Inc.

  • Media and Entertainment (2 percent)

  • Sector leader: SIRIUS XM Radio Access to Capital Is a Key Success FactorA majority -- 57 percent -- of the winners are public companies that have successfully raised capital through the public market.  Furthermore, 20 percent are private companies with a history of venture capital funding.  In a survey of the 2009 Technology Fast 500™ winners, nearly two-thirds of chief executive officers surveyed said they had no need to raise new capital to continue on their growth trajectories.  

    "It may not be surprising that a common trait of Fast 500 leaders is their sense of confidence in securing capital to maintain and grow their business," said Mark Jensen, managing partner, venture capital services, Deloitte & Touche LLP. "But it does serve as a good reminder that regions that lay the groundwork for strong local venture markets will be able to attract innovative, high-growth companies regardless of the economic climate."

    From a regional perspective, 36 percent of the Technology Fast 500 companies are from the West, with California once again as the standout with 143 companies on the list.  States in the Northeast and the Southeast also have a significant concentration of Technology Fast 500™ companies, with 28 percent and 14 percent, respectively.

    For additional detail on the Technology Fast 500™ including qualifying criteria, visit

    As used in this document, "Deloitte" means Deloitte LLP and its subsidiaries.  Please see for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.

    The 2010 Technology Fast 500™2010 RankCompanySectorRevenue Growth (2005 to 2009)City, State1

    Hughes Communications, Inc.

    Communications/ Networking

    164,079 percent

    Germantown, Md.2

    Affymax, Inc.


    155,169 percent

    Palo Alto, Calif.3

    Insulet Corporation

    Scientific/Technical Instrumentation

    131,964 percent

    Bedford, Mass.4

    Ener1, Inc.

    Clean Tech

    57,900 percent

    New York, N.Y.5

    BioCryst Pharmaceuticals, Inc.


    48,972 percent

    Birmingham, Ala.6

    Varicent Software Incorporated


    40,269 percent

    Toronto, ON7

    Alexion Pharmaceuticals, Inc.


    36,253 percent

    Cheshire, Conn.8

    Telanetix, Inc.

    Communications/ Networking

    27,276 percent

    Bellevue, Wash.9

    Onyx Pharmaceuticals, Inc.


    25,039 percent

    Emeryville, Calif.10

    Celldex Therapeutics, Inc.


    21,280 percent

    Needham, Mass.Contact:Jessica HeinePublic RelationsDeloitte+1 415 783

    SOURCE Deloitte
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Deloitte Recap Honors Sanofi-aventis and Exelixis With the Allicense 2010 Breakthrough Alliance Award for Early-Stage Collaboration in Cancer
    2. NeoStem Appoints Deloitte & Touche as New Independent Registered Public Accounting Firm
    3. Sundia Named Deloitte Technology Fast 500 Asia Pacific for 2nd Consecutive Year
    4. Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies
    5. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
    6. Cadient Group Ranks as Deloitte Fast 50 Company for Greater Philadelphia Region for Second Consecutive Year
    7. Deloitte Recap Launches New Series of Biopharmaceutical Business Intelligence Tools
    8. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
    9. Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report
    10. Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloittes 2008 Technology Fast 500
    11. Sinovac Named to Deloitte Technology Fast 50 China
    Post Your Comments:
    (Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
    (Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
    (Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
    (Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
    Breaking Biology Technology:
    (Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
    (Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
    (Date:10/29/2015)... Oct. 29, 2015  Connected health pioneer, Joseph ... explosion of technology-enabled health and wellness, and the business ... The Internet of Healthy Things . ... smartphones even existed, Dr. Kvedar, vice president, Connected Health, ... care delivery, moving care from the hospital or doctor,s ...
    Breaking Biology News(10 mins):